glp 1 drugs and blindness GLP-1 Drugs: An Ophthalmologist Explains glp 1 drugs blindness Do

[DOI] [PMC free article] [PubMed] [Google Scholar] 138.Su B, Sheng H, Zhang M, Bu L, Yang P, Li L, Li F, Sheng C, Han Y, Qu S, Wang J

Patients who are denied can appeal through the California Department of Health Care Services

GLP-1 protein expression was also detected in intestinal mucosal tissue

A major June 2025 study from the Cleveland Clinic revealed that over half of patients discontinued GLP-1 treatment within a year

There was also a treatment as usual (TAU) group (N= 1,513,896) with Type 2 DM who took non-GLP-1 antihyperglycemics between the study dates of October 1, 2017 and December 31, 2023

In patients with HFpEF and obesity, both semaglutide (STEP-HFpEF) and tirzepatide (SUMMIT) significantly reduced cardiovascular death and worsening heart failure events, with concomitant improvements in quality of life and functional capacity [3,47]